Product liability litigation regularly involves the highest stakes in cases of extreme complexity. Faced with such franchise-threatening matters, the world’s leading corporations trust Paul, Weiss to lead them to victory. Our superior ability to establish a winning, long-term strategy, our unique skill at breaking down and presenting complicated material, and our vaunted trial prowess make us counsel of choice in many of the most important product liability lawsuits.

Paul, Weiss Adds Renowned Trial Lawyer and Strategist

David M. Bernick has joined Paul, Weiss as a partner in its litigation department, resident in New York. 

» more

AbbVie Achieves Complete Defense Verdict

Paul, Weiss achieved a complete defense verdict for AbbVie Inc. in a products liability suit relating to AbbVie’s testosterone replacement therapy, concluding a two week trial in state court in Cook County, Illinois.

» more

Pfizer Achieves Trial Victory in Second Zoloft Birth Defects Case

Paul, Weiss client Pfizer achieved a major victory in the second Zoloft birth defects case to go to trial in the U.S. At the conclusion of an eight-day trial, a Philadelphia jury returned a complete defense verdict and concluded that Pfizer's warnings about the risks of Zoloft were adequate.

» more

Pfizer Wins First U.S. Trial Over Zoloft Birth-Defect Risk

As reported in BloombergReuters and other media outlets, Paul, Weiss client Pfizer achieved a major victory in the first Zoloft birth defects case to go to trial in the U.S. At the conclusion of a seven-day trial, a St. Louis jury returned a complete defense verdict in under two hours. The jury rejected the plaintiff's allegations that a mother's use of Zoloft in the first trimester of her pregnancy caused her child's cardiac birth defect.

» more

Pfizer Wins Dismissal of Shareholder Class Action Suit

As reported by Thomson Reuters and Law.com, Paul, Weiss client Pfizer Inc. achieved a major victory when a federal court granted the company's motion for summary judgment in In Re Pfizer Inc. Securities Litigation, a securities class action filed in the United States District Court for the Southern District of New York involving decade-old disclosures related to Celebrex and Bextra.

» more

© 2018 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy